{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T22:34:53Z","timestamp":1773441293392,"version":"3.50.1"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3109\/09546634.2012.660520","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T07:08:24Z","timestamp":1327388904000},"page":"38-49","source":"Crossref","is-referenced-by-count":27,"title":["Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature"],"prefix":"10.1080","volume":"24","author":[{"given":"SATVEER K.","family":"Mahil","sequence":"first","affiliation":[{"name":"St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"THOMASIN C.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guy's and St Thomas' NHS Foundation Trust","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHARLOTTE","family":"Brierley","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cambridge University Hospitals NHS Foundation Trust","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JONATHAN N.","family":"Barker","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CATHERINE H.","family":"Smith","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,3,11]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09505.x"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh464"},{"key":"e_1_3_2_5_1","article-title":"Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors","author":"Solomon AJ","unstructured":"Solomon AJ, Spain RI, Kruer MC, Bourdette D. Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler 2011; Epub ahead of print.","journal-title":"Mult Scler"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.10.1885"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archopht.120.7.985","article-title":"Retrobulbar optic neuritis associated with infliximab","volume":"120","author":"Foroozan R","year":"2002","unstructured":"Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol. 2002;120:985\u2013987.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200401000-00004"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000155126.82171.32"},{"key":"e_1_3_2_11_1","first-page":"1548","article-title":"Anti-tumor necrosis factor alpha-associated multiple sclerosis","volume":"26","author":"Titelbaum DS","year":"2005","unstructured":"Titelbaum DS, Degenhardt A, Kinkel RP. Anti-tumor necrosis factor alpha-associated multiple sclerosis. Am J Neuroradiol. 2005;26:1548\u20131550.","journal-title":"Am J Neuroradiol"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0055-1"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0097-x"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2005.12.002"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.11.002"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.3402\/ljm.v2i2.4703"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.05.039"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.5.793"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/358658"},{"key":"e_1_3_2_20_1","first-page":"1202","article-title":"Etanercept induced multiple sclerosis and transverse myelitis","volume":"33","author":"Al Saieg N","year":"2006","unstructured":"Al Saieg N, Luzar MJ. Etanercept induced multiple sclerosis and transverse myelitis. J Rheumatol. 2006;33:1202\u20131204.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_21_1","first-page":"1457","article-title":"Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab","volume":"33","author":"Ruiz-Jimeno T","year":"2006","unstructured":"Ruiz-Jimeno T, Carvajal A, Mata C, Aurrecoechea E. Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab. J Rheumatol. 2006;33:1457\u20131458.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_22_1","article-title":"Demyelination during TNF antagonist therapy for ankylosing spondylitis","author":"Mercieca C","year":"2011","unstructured":"Mercieca C, Vella N, Borg AA. Demyelination during TNF antagonist therapy for ankylosing spondylitis. Mod Rheumatol. 2011;Epub ahead of print; (PMID 21748364).","journal-title":"Mod Rheumatol"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00779.x"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740600557249"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000109576"},{"key":"e_1_3_2_26_1","first-page":"1469","article-title":"Demyelinating disease associated with use of etanercept in patients with seronegative spondyloarthropathies","volume":"35","author":"Davis SA","year":"2008","unstructured":"Davis SA, Johnson RR, Pendleton JW. Demyelinating disease associated with use of etanercept in patients with seronegative spondyloarthropathies. J Rheumatol. 2008;35:1469\u20131471.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2008.001741.x"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802136164"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.20452\/pamw.370","article-title":"Neurological disorders with demyelinating brain lesions in a patient with rheumatoid arthritis treated with etanercept","volume":"118","author":"Kur-Zalewska J","year":"2008","unstructured":"Kur-Zalewska J, Swarowska-Knap J, Ttustochowicz W. Neurological disorders with demyelinating brain lesions in a patient with rheumatoid arthritis treated with etanercept. Pol Arch Med Wewn. 2008;118:234\u2013237.","journal-title":"Pol Arch Med Wewn"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.496914"},{"key":"e_1_3_2_31_1","first-page":"239","article-title":"Adalimumab-associated multiple sclerosis","volume":"34","author":"Bensouda-Grimaldi L","year":"2007","unstructured":"Bensouda-Grimaldi L, Mulleman D, Valat JP, Autret-Leca E. Adalimumab-associated multiple sclerosis. J Rheumatol. 2007;34:239\u2013240.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.01.012"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.495814"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019126"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5591-7"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.06.004"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep423"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091025"},{"key":"e_1_3_2_39_1","first-page":"238","article-title":"Assessment of long term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis","volume":"29","author":"Klareskog L","year":"2011","unstructured":"Klareskog L, Gaubitz M, Rodriguez-Valverde V, Malaise M, Dougados M, Wajdula J; Etanercept Study 301 Investigators. Assessment of long term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2011;29:238\u2013247.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.035287"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1996.tb00004.x"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2000.101001036.x"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.022"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300510"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108153250704"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01315.x"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.4.1193"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)00139-F"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1531"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.457"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.2000.1706"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.4.427"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn738"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181441a68"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/09546634.2012.660520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:36:35Z","timestamp":1772710595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/09546634.2012.660520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3109\/09546634.2012.660520"],"URL":"https:\/\/doi.org\/10.3109\/09546634.2012.660520","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,11]]}}}